Role of GDF15 (growth and differentiation factor 15) in pulmonary oxygen toxicity

Toxicology in Vitro

Volumn 29, Issue 7, 2015, Pages 1369-1376

  Tiwari, Kirti Kumar ^a   Moorthy, Bhagavatula ^a   Lingappan, Krithika ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

BEAS 2B; Bronchopulmonary dysplasia; HPMEC; Hyperoxia; Pulmonary

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 15; SMALL INTERFERING RNA; GDF15 PROTEIN, HUMAN; MESSENGER RNA; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

ARTICLE; BRONCHUS MUCOSA; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HYPEROXIA; IN VITRO STUDY; OXIDATIVE STRESS; OXYGEN TOXICITY; PROTEIN EXPRESSION; PROTEIN FUNCTION; CELL LINE; CELL SURVIVAL; CYTOLOGY; ENDOTHELIUM CELL; GENETICS; LUNG; METABOLISM; RNA INTERFERENCE;

CELL LINE; CELL SURVIVAL; ENDOTHELIAL CELLS; EPITHELIAL CELLS; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; HYPEROXIA; LUNG; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84936763699     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2015.05.008     Document Type: Article

References (31)

1. Agarwal M.K., Hastak K., Jackson M.W., Breit S.N., Stark G.R., Agarwal M.L. Macrophage inhibitory cytokine 1 mediates a p53-dependent protective arrest in S phase in response to starvation for DNA precursors. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:16278-16283. 10.1073/pnas.0607210103.
2. Böttner M., Suter-Crazzolara C., Schober A., Unsicker K. Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues. Cell Tissue Res. 1999, 297:103-110.
3. Buczynski B.W., Maduekwe E.T., O'Reilly M.A. The role of hyperoxia in the pathogenesis of experimental BPD. Semin. Perinatol. 2013, 37:69-78. 10.1053/j.semperi.2013.01.002.
4. Clark B.J., Bull T.M., Benson A.B., Stream A.R., Macht M., Gaydos J., Meadows C., Burnham E.L., Moss M., the ARDS Network Investigators Growth differentiation factor-15 and prognosis in acute respiratory distress syndrome: a retrospective cohort study. Crit. Care 2013, 17:R92. 10.1186/cc12737.
5. Han E.-S., Muller F.L., Pérez V.I., Qi W., Liang H., Xi L., Fu C., Doyle E., Hickey M., Cornell J., Epstein C.J., Roberts L.J., Van Remmen H., Richardson A. The in vivo gene expression signature of oxidative stress. Physiol. Genomics 2008, 34:112-126. 10.1152/physiolgenomics.00239.2007.
6. Hilgendorff A., Reiss I., Ehrhardt H., Eickelberg O., Alvira C.M. Chronic lung disease in the preterm infant: lessons learned from animal models. Am. J. Respir. Cell Mol. Biol. 2013, 10.1165/rcmb.2013-0014TR.
7. Jin Y.-J., Lee J.-H., Kim Y.-M., Oh G.T., Lee H. Macrophage inhibitory cytokine-1 stimulates proliferation of human umbilical vein endothelial cells by up-regulating cyclins D1 and E through the PI3K/Akt-, ERK-, and JNK-dependent AP-1 and E2F activation signaling pathways. Cell. Signal. 2012, 24:1485-1495. 10.1016/j.cellsig.2012.03.014.
8. Kang S.U., Lee B.-S., Lee S.-H., Baek S.J., Shin Y.S., Kim C.-H. Expression of NSAID-activated gene-1 by EGCG in head and neck cancer: involvement of ATM-dependent p53 expression. J. Nutr. Biochem. 2013, 24:986-999. 10.1016/j.jnutbio.2012.07.003.
9. Kannan K., Amariglio N., Rechavi G., Givol D. Profile of gene expression regulated by induced p53: connection to the TGF-beta family. FEBS Lett. 2000, 470:77-82.
10. Kempf T., Wollert K.C. Risk stratification in critically ill patients: GDF-15 scores in adult respiratory distress syndrome. Crit. Care 2013, 17:173. 10.1186/cc12765.
11. Kempf T., Eden M., Strelau J., Naguib M., Willenbockel C., Tongers J., Heineke J., Kotlarz D., Xu J., Molkentin J.D., Niessen H.W., Drexler H., Wollert K.C. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circulat. Res. 2006, 98:351-360. 10.1161/01.RES.0000202805.73038.48.
12. Kempf T., Zarbock A., Widera C., Butz S., Stadtmann A., Rossaint J., Bolomini-Vittori M., Korf-Klingebiel M., Napp L.C., Hansen B., Kanwischer A., Bavendiek U., Beutel G., Hapke M., Sauer M.G., Laudanna C., Hogg N., Vestweber D., Wollert K.C. GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat. Med. 2011, 17:581-588. 10.1038/nm.2354.
13. Kim J.M., Kosak J.P., Kim J.K., Kissling G., Germolec D.R., Zeldin D.C., Bradbury J.A., Baek S.J., Eling T.E. NAG-1/GDF15 transgenic mouse has less white adipose tissue and a reduced inflammatory response. Mediators Inflamm. 2013, 2013:641851. 10.1155/2013/641851.
14. Li J., Yang L., Qin W., Zhang G., Yuan J., Wang F. Adaptive induction of growth differentiation factor 15 attenuates endothelial cell apoptosis in response to high glucose stimulus. PLoS ONE 2013, 8:e65549. 10.1371/journal.pone.0065549.
15. Lingappan K., Jiang W., Wang L., Couroucli X.I., Moorthy B. Analysis of the transcriptome in hyperoxic lung injury and sex-specific alterations in gene expression. PLoS ONE 2014, 9:e101581. 10.1371/journal.pone.0101581.t004.
16. Madurga A., Mizíková I., Ruiz-Camp J., Morty R.E. Recent advances in late lung development and the pathogenesis of bronchopulmonary dysplasia. AJP: Lung Cell. Mol. Physiol. 2013, 305:L893-905. 10.1152/ajplung.00267.2013.
17. Maniscalco W.M., Watkins R.H., Roper J.M., Staversky R., O'Reilly M.A. Hyperoxic ventilated premature baboons have increased p53, oxidant DNA damage and decreased VEGF expression. Pediatr. Res. 2005, 58:549-556. 10.1203/01.pdr.0000176923.79584.f7.
18. McGrath-Morrow S.A., Lauer T., Collaco J.M., Lopez A., Malhotra D., Alekseyev Y.O., Neptune E., Wise R., Biswal S. Transcriptional responses of neonatal mouse lung to hyperoxia by Nrf2 status. Cytokine 2014, 65:4-9. 10.1016/j.cyto.2013.09.021.
19. Nickel N., Jonigk D., Kempf T., Bockmeyer C.L., Maegel L., Rische J., Laenger F., Lehmann U., Sauer C., Greer M., Welte T., Hoeper M.M., Golpon H.A. GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells. Respir. Res. 2011, 12:62. 10.1186/1465-9921-12-62.
20. O'Reilly M.A. DNA damage and cell cycle checkpoints in hyperoxic lung injury: braking to facilitate repair. Am. J. Physiol. Lung Cell Mol. Physiol. 2001, 281:L291-305.
21. O'Reilly M.A., Staversky R.J., Stripp B.R., Finkelstein J.N. Exposure to hyperoxia induces p53 expression in mouse lung epithelium. Am. J. Respir. Cell Mol. Biol. 1998, 18:43-50. 10.1165/ajrcmb.18.1.2950m.
22. Osada M., Park H.L., Park M.J., Liu J.-W., Wu G., Trink B., Sidransky D. A p53-type response element in the GDF15 promoter confers high specificity for p53 activation. Biochem. Biophys. Res. Commun. 2007, 354:913-918. 10.1016/j.bbrc.2007.01.089.
23. Preusch M.R., Baeuerle M., Albrecht C., Blessing E., Bischof M., Katus H.A., Bea F. GDF-15 protects from macrophage accumulation in a mousemodel of advanced atherosclerosis. Eur. J. Med. Res. 2013, 18:19. 10.1186/2047-783X-18-19.
24. Saugstad O.D. Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin. Neonatol. 2003, 8:39-49.
25. Shenberger J.S., Dixon P.S. Oxygen induces S-phase growth arrest and increases p53 and p21(WAF1/CIP1) expression in human bronchial smooth-muscle cells. Am. J. Respir. Cell Mol. Biol. 1999, 21:395-402. 10.1165/ajrcmb.21.3.3604.
26. Song H., Yin D., Liu Z. GDF-15 promotes angiogenesis through modulating p53/HIF-1α signaling pathway in hypoxic human umbilical vein endothelial cells. Mol. Biol. Rep. 2012, 39:4017-4022. 10.1007/s11033-011-1182-7.
27. Subramaniam S., Strelau J., Unsicker K. Growth differentiation factor-15 prevents low potassium-induced cell death of cerebellar granule neurons by differential regulation of Akt and ERK pathways. J. Biol. Chem. 2003, 278:8904-8912. 10.1074/jbc.M210037200.
28. Wang X., Baek S.J., Eling T.E. The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer. Biochem. Pharmacol. 2013, 85:597-606. 10.1016/j.bcp.2012.11.025.
29. Wright C.J., Agboke F., Chen F., La P., Yang G., Dennery P.A. NO inhibits hyperoxia-induced NF-κB activation in neonatal pulmonary microvascular endothelial cells. Pediatr. Res. 2010, 68:484-489. 10.1203/PDR.0b013e3181f917b0.
30. Zhang M., Lin L., Lee S.J., Mo L., Cao J., Ifedigbo E., Jin Y. Deletion of caveolin-1 protects hyperoxia-induced apoptosis via survivin-mediated pathways. AJP: Lung Cell. Mol. Physiol. 2009, 297:L945-L953. 10.1152/ajplung.00081.2009.
31. Zimmers T.A., Jin X., Hsiao E.C., McGrath S.A., Esquela A.F., Koniaris L.G. Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock 2005, 23:543-548.